New Alzheimer's drug targets brain connections in early safety test
Disease control
Completed
This early-stage study tested the safety and side effects of an experimental drug called BMS-984923 in healthy older adults and people with early Alzheimer's disease. The main goal was to see if the drug was safe at different dose levels and to check if brain scans could detect c…
Phase: PHASE1 • Sponsor: Allyx Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC